Join to View Full Profile
4301 W Markham St# 783Little Rock, AR 72205
Phone+1 501-686-8000
Dr. Wolfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Adam Wolfe, MD, is a Radiation Oncologist specializing in Gastrointestinal Cancer based in Little Rock, AR. He earned his MD and PhD from McGovern Medical School at UTHealth in 2016 and completed his residency in Radiation Oncology at Ohio State University Hospital in 2021. Currently, he serves as an Assistant Professor at the University of Arkansas for Medical Sciences. His research includes publications focusing on radiosensitivity and radioresistance in pancreatic cancer, with contributions in reputable journals such as Radiotherapy and Oncology, Cancer Letters, and Science Advances.
Education & Training
Ohio State University HospitalResidency, Radiation Oncology, 2017 - 2021
Wayne State University School of MedicineInternship, Transitional Year, 2016 - 2017
McGovern Medical School at UTHealthClass of 2016, MD, PhD
Texas Tech UniversityBS, Cell and Molecular Biology, Summa Cum Laude, 2005 - 2009
Certifications & Licensure
FL State Medical License 2025 - 2027
SC State Medical License 2025 - 2027
AR State Medical License 2021 - 2025
OH State Medical License 2017 - 2021
MI State Medical License 2016 - 2017
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience.Kaidi Wang, Pouya Sabouri, Adam Wolfe, Eric Siegel, John Marrufo
International Journal of Radiation Oncology, Biology, Physics. 2025-09-15 - Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1.Stetson Van Matre, Saaimatul Huq, Lokesh Akana, Daniel E Eldridge, Oscar Zuniga
Radiotherapy and Oncology. 2024-11-01 - 4 citationsRAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers.Adam R Wolfe, Haihua Feng, Oscar Zuniga, Henrique Rodrigues, Daniel E Eldridge
Cancer Letters. 2024-06-01
Press Mentions
American Cancer Society Funds UAMS Study To Understand Treatment Resistance in Pancreatic CancerJuly 13th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
